Verified earnings results

Generate Biomedicines Q3 2026 Earnings Results

Direct answer

Generate Biomedicines reported Q3 2026 results on November 12, 2026.

Revenue was 4,220,000. EPS missed the estimate by 19.76%.
The result is verified against Verified earnings source.
Verified earnings source

Get free Generate Biomedicines email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Earnings date
November 12, 2026
Reported timing
Before the US market opens
EPS estimate
-0.5678
Reported EPS
-0.68
Revenue
4,220,000
EPS surprise
EPS missed the estimate by 19.76%.

Read the frequently asked questions.

When did Generate Biomedicines report Q3 2026 earnings?

Generate Biomedicines reported on November 12, 2026. The reported timing was before the us market opens.

What is the available EPS estimate for Generate Biomedicines?

The verified record provides an EPS estimate of -0.5678.

Has Generate Biomedicines reported the Q3 2026 result?

Revenue was 4,220,000. EPS missed the estimate by 19.76%.

Which source supports this Generate Biomedicines earnings record?

The earnings record identifies Verified earnings source as its source. Missing values are not estimated.